Jeannine D. Rinderknecht

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

Reinhard Dummer, Simone M. Goldinger, Christian P. Turtschi et al. · European Journal of Cancer · 2013 · 286 citations

Neuro-oncology, Open-label Pilot Study, Medicine +8

Accelerated clearance of small solutes from the lungs in interstitial lung disease.

Jeannine D. Rinderknecht, Lee Shapiro, M Krauthammer et al. · PubMed · 1980 · 165 citations

99Mtc-dtpa Clearance, Inflammatory Lung Disease, Advanced Lung Disease +18

RASopathic Skin Eruptions during Vemurafenib Therapy

Jeannine D. Rinderknecht, Simone M. Goldinger, Sima Rozati et al. · PLoS ONE · 2013 · 81 citations · Full text

An open-label pilot study of vemurafenib in previously treated metastatic melanoma patients with brain metastases.

Reinhard Dummer, Jeannine D. Rinderknecht, Simone M. Goldinger et al. · Journal of Clinical Oncology · 2011 · 62 citations

Surgical Oncology, Brain Metastases, Pathology +16

A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma

Simone M. Goldinger, Jeannine D. Rinderknecht, Reinhard Dummer et al. · Pharmacology Research & Perspectives · 2015 · 27 citations · Full text